AMBRISENTAN News

← Back to News Overview

---

AMBRISENTAN currently has 0 news articles, with 11 predicted indications.

This page combines the AI-predicted indications for AMBRISENTAN with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Evidence level: L5
• Predicted indications (11):
  • pulmonary arterial hypertension (99.0%)
  • pulmonary arteriovenous malformation (disease) (99.4%)
  • pulmonary arterial hypertension associated with congenital heart disease (99.4%)
  • pulmonary arterial hypertension associated with HIV infection (99.3%)
  • pulmonary arterial hypertension associated with connective tissue disease (99.3%)
  • pulmonary arterial hypertension associated with chronic hemolytic anemia (99.3%)
  • pulmonary arterial hypertension associated with schistosomiasis (99.3%)
  • malformation syndrome with odontal and/or periodontal component (99.2%)
  • hypotrichosis simplex of the scalp (99.2%)
  • hypertrichosis (disease) (99.1%)
  • syndrome with a Dandy-Walker malformation as major feature (99.1%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.